|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Budesonide>> Market Analysis Reports |
Market Analysis Reports of Budesonide |
|
Budesonide;Budeson;Preferid;Pulmicort (CAS 51333-22-3) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). R-Budesonide (CAS 51372-29-3) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Budesonide acetonide (CAS 638-94-8) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Budesonide (CAS 427-51-0) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Bupropion Hydrochloride (CAS 34841-39-9) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Global Market Report of Budesonide (CAS 51333-22-3) December 2024 Investigation Report on China Budesonide Market, 2018-2022 ... was approved to manufacture and sell Budesonide in China. Budesonide has been developing rapidly ... Market share of various dosage forms of Budesonide in China Budesonide prices on the Chinese market ... Investigation Report on Chinese Budesonide Market 2021-2025 ... a CAGR of approximately 9.26%. However, the sales of Budesonide decreased by 29.30% in 2020 because of the COVID ... Competitive landscape of China's budesonide market Prices of budesonide in China Prices of budesonide in China by regions and ... MAP Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... headache specialists. Nebulized Budesonide Unit Dose Budesonide, or UDB, is the ... s proprietary nebulized version of budesonide intended to treat asthma in children from ... its proprietary nebulized formulation of budesonide. The company is jointly developing ... Nicox SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... 1020, a nitric oxide-donating derivative of budesonide is in phase I/IIa clinical trials for ... is an inhaled nitric oxide-donating derivative of budesonide, a corticosteroid marketed by AstraZeneca plc, of London ... Global Market Report of 6-BETA-HYDROXY BUDESONIDE (CAS 88411-77-2) December 2024 Global Market Report of (R)-Budesonide (CAS 51372-29-3) December 2024 Ahlcon Parenterals (India) Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... , including salbutamol respiratory solution and budesonide respiratory suspension; and plasma volume ... AstraZeneca PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... Consumer Care AG was announced. Entocort (budesonide) is a locally acting corticosteroid for the ... Cosmo Pharmaceuticals S.p.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... companys clinical development products include Budesonide MMX, a Phase III clinical trial ... Inyx Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... Beclomethasone. It is also reviewing the use of Budesonide, an anti-inflammatory corticosteroid, and Formeterol ... Santarus Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... rights to develops and commercializes the budesonide MMX and rifamycin SV MMX product ... SkyePharma plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... containing AstraZenecas inhaled corticosteroid Pulmicort (budesonide), which was developed for territories ... Teva Pharmaceutical Industries Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... ), Eloxatin (oxaliplatin), Casodex (bicalutamide), Rhinocort (budesonide), Effexor (venlafaxine HCl), Protonix (pantoprazole ... Theravance Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... by GSK), formoterol, and formoterol and budesonide as a combination (marketed by AstraZeneca), and tiotropium ... |